Search

everythinglearnresearchcommunity

for

Search:↓

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

CMV infection increases the risk of GvHD after bone marrow transplants.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Tislelizumab can cause cutaneous lupus erythematosus.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

IL-18 signaling helps mature Tregs move into the thymus.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

PCFCL may have unrecognized subtypes and needs more research.